iShares Biotechnology ETF
928 hedge funds and large institutions have $6.91B invested in iShares Biotechnology ETF in 2025 Q4 according to their latest regulatory filings, with 200 funds opening new positions, 272 increasing their positions, 216 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
16% more funds holding
Funds holding: 798 → 928 (+130)
2.63% more ownership
Funds ownership: 80.02% → 82.65% (+2.6%)
1% less call options, than puts
Call options by funds: $257M | Put options by funds: $260M
Holders
928
Holding in Top 10
11
Calls
$257M
Puts
$260M
Top Buyers
| 1 | +$247M | |
| 2 | +$229M | |
| 3 | +$190M | |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
+$120M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$107M |
Top Sellers
| 1 | -$218M | |
| 2 | -$116M | |
| 3 | -$34M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$28.9M |
| 5 |
ERSOT
Employees Retirement System of Texas
Austin,
Texas
|
-$28.3M |
